<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, immunohistochemical analysis was employed to assess ENO1. Figure 
 <xref rid="Fig3" ref-type="fig">3</xref> shows representative examples of immunostaining for ENO1 in primary and metastatic tumors. Both western blotting and immunohistochemistry confirmed the findings of LC–MS/MS analysis. 
</p>
